Date Initiated by Firm |
February 21, 2022 |
Create Date |
April 04, 2022 |
Recall Status1 |
Open3, Classified |
Recall Number |
Z-0856-2022 |
Recall Event ID |
89687 |
510(K)Number |
K202000
|
Product Classification |
Oral wound dressing - Product Code OLR
|
Product |
Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm |
Code Information |
Product Number: 69420-8351-1
Lot Number: U701SF1
UDI Code: N/A |
Recalling Firm/ Manufacturer |
SA3, LLC 2317 Cotner Ave Los Angeles CA 90064-1803
|
For Additional Information Contact |
Farbod Melamed 310-282-8086
|
Manufacturer Reason for Recall |
Due to failure of microbial testing for total aerobic microbial count (TAMC).
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
On 02/21/2022, the firm emailed an Urgent Recall Notification to customers informing them that the recall has been initiated due to the affected lot's microbial testing results for total aerobic microbial count (TAMC exceeded specifications prior to expiry of the gel.
Customer are instructed to:
1. Immediately examine your inventory and quarantine product subject to this recall.
2. Immediately discontinue use and distribution of the identified lot number.
3. To request a prepaid shipping label, complete and return the enclosed Customer Market
Withdrawal Return Response Form via email at info@alexso.com or via fax at 888-502-1669.
4. If customer have further distributed this product to other wholesalers or pharmacies, please identify and notify them at once of this product market recall. The Recall notification and return response form should be include when notifying these customers.
5. Return the affected product to:
Alexso, Inc.
c/o Recall
2317 Cotner Ave
Los Angeles, CA 90064
For any questions, contact the Recalling Firm at (888)-495-6078, Monday through Friday 9:00 AM to 5:00 PM PST or email at info@alexso.com.
On 03/07/2022, the firm emailed an updated "URGENT: Medical Device Market Removal" letter which informs customers of the potential risks/harms/hazards associated with use of the affected products and added that it is recommended that physicians monitor their patents for potential adverse reactions and events as a result of use of the affected product. |
Quantity in Commerce |
156 units |
Distribution |
U.S. Nationwide distribution in the states of CA, FL and GA.
|
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
510(K) Database |
510(K)s with Product Code = OLR and Original Applicant = SA3, LLC
|